BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Accelerates Portfolio Expansion, Setting Up Near-Term Catalysts
![]() |
Company activity and fresh VOXZOGO data create near-term positive momentum, while balance-sheet metrics and WMDST’s valuation point to stretched multiples. The technical setup shows short-term bullish momentum with cautionary overvaluation signals. |








